Stock info Bio-Path Holdings | Filter  Basic-Info

Stock: Bio-Path Holdings (US broad)

Last Price 3.23 Max Price 6.51
Min Price 0.36 1 Year return 100.00
Sector Health Care Subsector Biotechnology

Loading...

Contact info:Country: USAWebsite: www.bioaoldings.com

Sector Review Bio-Path Holdings

Loading...
Year Turnover Total sector Market share
2019 0 141,925 0.00 %
2020 0 170,231 0.00 %
2021 0 252,886 0.00 %
2022 0 238,500 0.00 %
2023 0 0 0.00 %

Advice Bio-Path Holdings

No Records Found




News Bio-Path Holdings

No Records Found

Annual reports Bio-Path Holdings

No Records Found


Profile Bio-Path Holdings

Bio-Path Holdings


The past year was a profitable year for the Bio-Path Holdings investors

The period between December 2015 and December 2016 was a loss-making period for the investors in Bio-Path Holdings. The stock lost around 38 percent. The period between August 2011 and August 2016 was a bad period for the investors. The stock lost around 0 percent.

Bio-Path Holdings primarily operates in the pharmaceutical sector. The global pharmaceutical companies gained around 75 percent worldwide over the last 10 years. Measured since 2011 the sector is 147 percent higher and over the past 12 months (December 2015-December 2016) there is a minus of 75 percent.

Bio-Path Holdings didn't pay out any dividends (in the past 5 years).

Bio-Path Holdings financed with relatively low debt

At the end of 2015 the pharmaceutical company's balance sheet was worth 0 million dollars. 0 million dollars ( percent of the total balance sheet) was financed by debt.

All Bio-Path Holdings's annual reports can be found here. More information about Bio-Path Holdings can be found it's website. .


Results Bio-Path Holdings

Results
2015
2016
2017
2018
2019
2020
Revenue
0
0
0
0
0
Costs
5
7
8
9
9
11
Profit
-5
-7
-8
-9
-9
-11
Margin of profit
0.0
-67500.00
-20150.00
0.0
0.0
ROI
-55.70
-81.92
-99.88
-703.28
-40.78
-72.20

Balance Bio-Path Holdings

Balance
2015
2016
2017
2018
2019
2020
Equity
10
8
8
1
21
15
Debt
1
4
1
1
2
1
Total assets
11
12
9
3
23
16
Solvency
91.26
67.54
91.08
47.84
93.07
91.44
Cash
9
9
6
1
20
14
Cashflow
-5
-8
-8
-6
-8
-11
Employees
0
0
0
0
0
Revenue per employee
0.0
0.0
0.0
0.0
0.0
Cashflow / Debt
-5.32
-2.06
-10.08
-4.60
-5.32
-7.77

Details Bio-Path Holdings

Details
2016
2017
2018
2019
2020
Price
250.00
270.00
40.50
3.50
7.99
Eps
-14.56
-15.99
-14.38
-3.24
-2.83
Price/earnings-ratio
-17.17
-16.89
-2.82
-1.08
-1.07
Dividend
0.0
0.0
0.0
0.0
Dividend %
0.00 %
0.00 %
0.00 %
0.00 %
Payout %
0.0
0.0
0.0
0.0
Book value
17.23
14.23
1.79
5.71
3.32
Market to book
0.07
0.05
0.04
1.63
1.10
Cashflow per stock
-17.04
-14.04
-9.00
-2.26
-2.41
Stocks
0
1
1
4
5
Market Cap
119.56
153.08
27.54
12.92
13.72

Dividend Bio-Path Holdings


Price info Bio-Path Holdings

Date
Price
17 Apr 2024
3.02
09 Apr 2024
3.92
05 Apr 2024
4.28
03 Apr 2024
4.41
30 Mar 2024
4.22
22 Mar 2024
4.23
18 Mar 2024
4.86
15 Mar 2024
5.12
12 Mar 2024
5.25
11 Mar 2024
5.83
09 Mar 2024
5.83
07 Mar 2024
6.51
01 Mar 2024
6.03
29 Feb 2024
6.03
27 Feb 2024
5.80
22 Feb 2024
0.44
21 Feb 2024
0.42
20 Feb 2024
0.43
15 Feb 2024
0.46
14 Feb 2024
0.46
13 Feb 2024
0.46
09 Feb 2024
0.45
08 Feb 2024
0.46
07 Feb 2024
0.47
06 Feb 2024
0.44
05 Feb 2024
0.44
01 Feb 2024
0.43
31 Jan 2024
0.43
30 Jan 2024
0.43
27 Jan 2024
0.43